Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dopamine DRD2/ANKK1 Taq1A and DAT1 VNTR polymorphisms are associated with a cognitive flexibility profile in pathological gamblers

  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Verdejo-Garcia, Antonio|||0000-0001-8874-9339
  • Granero, Roser|||0000-0001-6308-3198
  • Penelo Werner, Eva|||0000-0001-6796-7660
  • Gené Badia, Manel
  • Barrot, Carme|||0000-0002-3141-4092
  • Sánchez, Cristina
  • Alvarez Moya, Eva Maria|||0000-0002-3723-3225
  • Ochoa, Cristian|||0000-0002-4508-0951
  • Aymamí, Neus|||0000-0002-4607-9565
  • Gomez-Peña, Monica|||0000-0001-6194-8266
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
Like drug addiction, pathological gambling (PG) has been associated with impairments in executive functions and alterations in dopaminergic functioning; however, the role of dopamine (DA) in the executive profile of PG remains unclear. The aim of this study was to identify whether the DRD2/ANKK1 Taq1Ars1800497 and the DAT1-40 bp VNTR polymorphisms are associated with cognitive flexibility (measured by Wisconsin Card Sorting Test (WCST) and Trail Making Test (TMT)) and inhibition response (measured by Stroop Color and Word Test (SCWT)), in a clinical sample of 69 PG patients. Our results showed an association between DA functioning and cognitive flexibility performance. The Taq1A A1+ (A1A2/A1A1) genotype was associated with poorer TMT performance (p < 0.05), while DAT1 9-repeat homozygotes displayed better WCST performance (p < 0.05) than either 10-repeat homozygotes or heterozygotes. We did not find any association between the DRD2 or DAT1 polymorphisms and the inhibition response. These results suggested that pathological gamblers with genetic predispositions toward lower availability of DA and D2 receptor density are at a higher risk of cognitive flexibility difficulties. Future studies should aim to shed more light on the genetic mechanisms underlying the executive profile in PG.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mediational role of age of onset in gambling disorder, a path modeling analysis

  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Granero, Roser|||0000-0001-6308-3198
  • Tárrega Larrea, Salomé|||0000-0002-5820-6795
  • Angulo-Brunet, Ariadna|||0000-0002-0583-1618
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Arcelus, Jon|||0000-0002-3805-0180
  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Aymamí, Neus|||0000-0002-4607-9565
  • Moragas, Laura|||0000-0001-5235-7026
  • Sauvaget, Anne|||0000-0002-1822-8535
  • Grall-Bronnec, Marie|||0000-0003-0722-7243
  • Gomez-Peña, Monica|||0000-0001-6194-8266
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
The aim of the study is to assess a mediational pathway which includes patients' sex, personality traits, age of onset of gambling disorder (GD) and gambling-related variables. Method: the South Oaks Gambling Screen (SOGS), the Symptom Checklist (SCL-90-R) and the Temperament and Character Inventory-R (TCI-R) were administered to a large sample of 1,632 outpatients attending a specialized outpatient GD unit. Sociodemographic variables were also recorded. A Structural Equation Model (SEM) was adjusted to assess the pathway. Results: age of onset mediated between personality profile (novelty seeking and selftranscendence) and GD severity and depression symptoms (measured by SCL-90-R). Sex had a direct effect on GD onset and depression symptoms: men initiated the GD disorder earlier and reported fewer depression symptoms. Discussion: age of onset is a mediating variable between sex, personality traits, GD severity and depression symptoms. These empirical results provide new evidence about the underlying etiological process of dysfunctional behaviors related to gambling, and may help to guide the development of more effective treatment and prevention programs aimed at high-risk groups such as young men with high levels of novelty seeking and self-transcendence.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interaction between Orexin-A and sleep quality in females in extreme weight conditions

  • Sauchelli, Sarah|||0000-0003-3620-7671
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Garrido Sánchez, Lourdes|||0000-0003-0756-9606
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Casanueva, Felipe F.|||0000-0002-9052-8161
  • Baños, Rosa|||0000-0003-0626-7665
  • Botella, Cristina|||0000-0001-8783-6959
  • Crujeiras, Ana B.|||0000-0003-4392-0301
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
  • Frühbeck, Gema|||0000-0002-8305-7154
  • Granero, Roser|||0000-0001-6308-3198
  • Ortega, Francisco|||0000-0003-0039-1593
  • Rodríguez, Amaia|||0000-0002-2180-461X
  • Zipfel, Stephan|||0000-0003-1659-4440
  • Giel, Katrin E.|||0000-0003-0938-4402
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
The current study examined the relationship between plasma orexin-A and sleep in obesity. Concentrations of orexin-A and sleep were evaluated in 26 obese, 40 morbid obese and 32 healthy-weight participants. The sleep monitor Actiwatch AW7 and the Pittsburgh Sleep Quality Index were used to evaluate sleep. The Symptom Checklist-90-Revised was administered to assess symptoms of psychopathology. A higher weight status was associated with elevated orexin-A levels (p = .050), greater depression, anxiety and somatization symptoms (all: p < .001), and impoverished self-reported sleep quality (p < .001). A quadratic trend was found in objective sleep time, being longest in the obese group (p = .031). Structural equation modeling showed plasma orexin-A to be related to poor total sleep quality, which in turn was associated with elevated body mass index. Our data confirm an interaction between elevated plasma orexinA concentrations and poor sleep that contributes to fluctuations in body mass index.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Orexin and sleep quality in anorexia nervosa, clinical relevance and influence on treatment outcome

  • Sauchelli, Sarah|||0000-0003-3620-7671
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Sánchez Díaz, Isabel María|||0000-0001-5874-8204
  • Riesco, Nadine|||0000-0002-6336-4907
  • Custal, Núria
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Garrido Sánchez, Lourdes|||0000-0003-0756-9606
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Steiger, Howard|||0000-0003-4887-7824
  • Israel, Mimi|||0000-0003-0962-3514
  • Baños, Rosa|||0000-0003-0626-7665
  • Botella, Cristina|||0000-0001-8783-6959
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
  • Ortega, Francisco|||0000-0003-0039-1593
  • Frühbeck, Gema|||0000-0002-8305-7154
  • Granero, Roser|||0000-0001-6308-3198
  • Tárrega Larrea, Salomé|||0000-0002-5820-6795
  • Crujeiras, Ana B.|||0000-0003-4392-0301
  • Rodríguez, Amaia|||0000-0002-2180-461X
  • Estivill, Xavier|||0000-0002-0723-2256
  • Beckmann, Jacques S.|||0000-0002-9741-1900
  • Casanueva, Felipe F.|||0000-0002-9052-8161
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Background and aims: Orexins/hypocretins are orexigenic peptides implicated in the regulation of feedingbehavior and the sleep/wake cycle. Little is known about the functioning of these peptides in anorexianervosa (AN). The aims of the current study were to evaluate the extent to which orexin-A might belinked to sleep and treatment outcome in AN.Method: Fasting plasma orexin-A concentrations were measured in 48 females with AN at the start of a dayhospital treatment and in 98 normaleater/healthy-weight controls. The Pittsburgh Sleep Quality Indexwas administered at the beginning of the treatment as a measure of sleep quality. Other psychopatho-logical variables were evaluated with the Symptom Checklist-Revised (SCL90R) and the Eating DisorderInventory-2 (EDI). Patients were assessed at the start and end of treatment by means of commonly useddiagnostic criteria and clinical questionnaires.Results: The AN patients presented more sleep disturbances and poorer overall sleep quality than didthe healthy controls (p = .026) but there were no global differences between groups in plasma orexin-Aconcentrations (p = .071). In the AN sample, orexin-A concentrations were associated with greater sleepdisturbances (|r| = .30), sleep inefficiency (|r| = .22) and poorer overall sleep (|r| = .22). Structural EquationModeling (SEM) showed that both elevated orexin-A concentrations and inadequate sleep predictedpoorer treatment outcome.contribute to poor sleep quality in AN, and both of these variables are associated with therapy response.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex

  • Guadalupe, Tulio
  • Mathias, Samuel R.
  • vanErp, Theo G. M.
  • Whelan, Christopher D.|||0000-0003-0308-5583
  • Zwiers, Marcel P.|||0000-0001-5483-2935
  • Abe, Yoshinari|||0000-0001-8348-0801
  • Abramovic, Lucija
  • Agartz, Ingrid|||0000-0002-9839-5391
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Arias-Vásquez, Alejandro|||0000-0002-4786-0169
  • Aribisala, Benjamin S.
  • Armstrong, Nicola|||0000-0002-4477-293X
  • Arolt, Volker|||0000-0002-2445-9778
  • Artiges, Eric
  • Ayesa-Arriola, Rosa|||0000-0003-0570-5352
  • Baboyan, Vatche G.
  • Banaschewski, Tobias
  • Barker, Gareth John|||0000-0002-5214-7421
  • Bastin, Mark E.
  • Baune, Bernhard T.|||0000-0001-6548-426X
  • Blangero, John
  • Bokde, Arun L. W.
  • Boedhoe, Premika
  • Bose, Anushree|||0000-0002-3394-1646
  • Brem, Silvia
  • Brodaty, Henry|||0000-0001-9487-6617
  • Bromberg, Uli
  • Brooks, Samantha
  • Büchel, Christian
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Calhoun, Vince
  • Cannon, Dara M.
  • Cattrell, Anna
  • Cheng, Yuqi
  • Conrod, Patricia
  • Conzelmann, Annette
  • Corvin, Aiden
  • Crespo-Facorro, Benedicto|||0000-0003-0033-7132
  • Crivello, Fabrice|||0000-0001-6950-984X
  • Dannlowski, Udo|||0000-0002-0623-3759
  • de Zubicaray, Greig|||0000-0003-4506-0579
  • De Zwarte, Sonja M. C.
  • Deary, Ian J.|||0000-0002-1733-263X
  • Desrivières, Sylvane|||0000-0002-9120-7060
  • Doan, Nhat Trung
  • Donohoe, Gary
  • Dørum, Erlend S.
  • Ehrlich, Stefan|||0000-0003-2132-4445
  • Espeseth, Thomas
  • Fernández, Guillén
  • Flor, Herta|||0000-0003-4809-5398
  • Fouche, Jean-Paul|||0000-0002-0830-2324
  • Frouin, Vincent
  • Fukunaga, Masaki
  • Gallinat, Jürgen
  • Garavan, Hugh P.
  • Gill, Michael
  • Suarez, Andrea Gonzalez
  • Gowland, Penny
  • Grabe, Hans J.|||0000-0003-3684-4208
  • Grotegerd, Dominik
  • Gruber, Oliver
  • Hagenaars, Saskia
  • Hashimoto, Ryota
  • Hauser, Tobias U.|||0000-0002-7997-8137
  • Heinz, Andreas
  • Hibar, Derrek P.
  • Hoekstra, Pieter J.
  • Hoogman, Martine|||0000-0002-1261-7628
  • Howells, Fleur M.|||0000-0001-9759-2556
  • Hu, Hao
  • Hulshoff Pol, Hilleke E.|||0000-0002-2038-5281
  • Huyser, Chaim|||0000-0001-8757-3124
  • Ittermann, Bernd
  • Jahanshad, Neda|||0000-0003-4401-8950
  • Jönsson, Erik G.|||0000-0001-8368-6332
  • Jurk, Sarah
  • Kahn, Rene S.
  • Kelly, Sinead
  • Kraemer, Bernd
  • Kugel, Harald
  • Kwon, Jun Soo|||0000-0002-1060-1462
  • Lemaitre, Herve
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Lochner, Christine|||0000-0002-4766-3704
  • Luciano, Michelle|||0000-0002-7306-3008
  • Marquand, Andre F.|||0000-0001-5903-203X
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Martinot, Jean-Luc
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Mather, Karen A.|||0000-0003-4143-8941
  • McDonald, Colm|||0000-0003-1661-5192
  • McMahon, Katie L.
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Morris, Derek W.
  • Mothersill, Omar
  • Maniega, Susana Munoz
  • Mwangi, Benson|||0000-0002-1717-4395
  • Nakamae, Takashi|||0000-0003-4265-198X
  • Nakao, Tomohiro
  • Narayanaswaamy, Janardhanan C.
  • Nees, Frauke|||0000-0002-7796-8234
  • Nordvik, Jan E.
  • Onnink, A. Marten H.
  • Opel, Nils
  • Ophoff, Roel
  • Paillère Martinot, Marie-Laure
  • Papadopoulos Orfanos, Dimitri
  • Pauli, Paul
  • Paus, Tomáš
  • Poustka, Luise
  • Reddy, Janardhan YC.
  • Rentería, Miguel E.|||0000-0003-4626-7248
  • Roiz-Santiáñez, Roberto
  • Roos, Annerine
  • Royle, Natalie A.
  • Sachdev, Perminder
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Schmaal, Lianne|||0000-0001-9822-048X
  • Schumann, Gunter
  • Shumskaya, Elena
  • Smolka, Michael N.
  • Soares, Jair C.|||0000-0002-5466-5628
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Stein, Dan J.|||0000-0001-7218-7810
  • Strike, Lachlan|||0000-0003-2885-5898
  • Toro, Roberto
  • Turner, Jessica A.
  • Tzourio-Mazoyer, Nathalie
  • Uhlmann, Anne|||0000-0002-1753-7811
  • Hernández, Maria Valdés
  • van den Heuvel, Odile A.|||0000-0002-9804-7653
  • van der Meer, Dennis|||0000-0002-0466-386X
  • van Haren, Neeltje E. M.
  • Veltman, Dick J.
  • Venkatasubramanian, Ganesan|||0000-0002-0949-898X
  • Vetter, Nora C.
  • Vuletic, Daniella
  • Walitza, Susanne|||0000-0002-8161-8683
  • Walter, Henrik|||0000-0002-9403-6121
  • Walton, Esther|||0000-0002-0935-2200
  • Wang, Zhen|||0000-0003-4319-5314
  • Wardlaw, Joanna|||0000-0002-9812-6642
  • Wen, Wei|||0000-0003-2753-3870
  • Westlye, Lars T.|||0000-0001-8644-956X
  • Whelan, Robert
  • Wittfeld, Katharina|||0000-0003-4383-5043
  • Wolfers, Thomas
  • Wright, Margaret J.|||0000-0001-7133-4970
  • Xu, Jian
  • Xu, Xiufeng
  • Yun, Je-Yeon|||0000-0002-5531-2410
  • Zhao, Jingjing
  • Franke, Barbara|||0000-0003-4375-6572
  • Thompson, Paul M.|||0000-0002-4720-8867
  • Glahn, David C.|||0000-0002-4749-6977
  • Mazoyer, Bernard|||0000-0003-0970-2837
  • Fisher, Simon E.|||0000-0002-3132-1996
  • Francks, Clyde|||0000-0002-9098-890X
The online version of this article (doi:10.1007/s11682-016-9629-z) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression, a longitudinal neuroimaging study

  • Cano, M.
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Bernabéu-Sanz, Á.
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Hernández-Ribas, R.
  • Via, Esther|||0000-0002-2331-3232
  • De Arriba-Arnau, Aida|||0000-0002-7877-7341
  • Gálvez, V.
  • Urretavizcaya, M.
  • Pujol Nuez, Jesús|||0000-0002-9946-4547
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Soriano-Mas, Carles|||0000-0003-4574-6597
Recent research suggests that neuroplastic and neuroinflammatory changes may account for the mode of action of electroconvulsive therapy (ECT), although extant data do not allow for a clear disambiguation between these two hypotheses. Multimodal neuroimaging approaches (for example, combining structural and metabolic information) may help in clarifying this issue. Here we aimed to assess longitudinal changes in (i) regional gray matter (GM) volumes and (ii) hippocampal metabolite concentrations throughout an acute course of bitemporal ECT, as well as (iii) to determine the association between imaging changes and clinical improvement. We assessed 12 patients with treatment-resistant depression (TRD) at four time points (pre-treatment, after the first ECT session, after the ninth ECT session and 15 days after ECT course completion) and 10 healthy participants at two time points, 5 weeks apart. Patients with TRD showed bilateral medial temporal lobe (MTL) and perigenual anterior cingulate cortex volume increases. Left MTL volume increase was associated with (i) a hippocampal N -acetylaspartate concentration decrease, (ii) a hippocampal Glutamate+Glutamine concentration increase and (iii) significant clinical improvement. The observed findings are, in part, compatible with both neuroplastic and neuroinflammatory changes induced by ECT. We postulate that such phenomena may be interrelated, therefore reconciling the neuroplasticity and neuroinflammatory hypotheses of ECT action.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women

  • Pastor, Antoni|||0000-0003-3692-0696
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Botella, Cristina|||0000-0001-8783-6959
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
  • Frühbeck, Gema|||0000-0002-8305-7154
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Rodríguez, Joan
  • Agüera, Zaida|||0000-0003-4453-4939
  • Langohr, Klaus|||0000-0001-7075-9192
  • Casanueva, Felipe F.|||0000-0002-9052-8161
  • Torre, Rafael de la|||0000-0002-6765-1866
The endocannabinoid (eCB) system can promote food intake by increasing odor detection in mice. The eCB system is over-active in human obesity. Our aim is to measure circulating eCB concentrations and olfactory capacity in a human sample that includes people with obesity and explore the possible interaction between olfaction, obesity and the eCB system. The study sample was made up of 161 females with five groups of body mass index sub-categories ranging from under-weight to morbidly obese. We assessed olfactory capacity with the "Sniffin'Sticks" test, which measures olfactory threshold-discrimination-identification (TDI) capacity. We measured plasma concentrations of the eCBs 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine or anandamide (AEA), and several eCB-related compounds, 2-acylglycerols and N-acylethanolamines. 2-AG and other 2-acylglycerols fasting plasma circulating plasma concentrations were higher in obese and morbidly obese subjects. AEA and other N-acylethanolamine circulating concentrations were lower in under-weight subjects. Olfactory TDI scores were lower in obese and morbidly obese subjects. Lower TDI scores were independently associated with higher 2-AG fasting plasma circulating concentrations, higher %body fat, and higher body mass index, after controlling for age, smoking, menstruation, and use of contraceptives. Our results show that obese subjects have a lower olfactory capacity than non-obese ones and that elevated fasting plasma circulating 2-AG concentrations in obesity are linked to a lower olfactory capacity. In agreement with previous studies we show that eCBs AEA and 2-AG, and their respective congeners have a distinct profile in relation to body mass index. The present report is the first study in humans in which olfactory capacity and circulating eCB concentrations have been measured in the same subjects.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Emotion Regulation and Excess Weight, Impaired Affective Processing Characterized by Dysfunctional Insula Activation and Connectivity

  • Steward, Trevor|||0000-0003-3116-8175
  • Picó-Pérez, Maria|||0000-0002-1573-2445
  • Mata, Fernanda
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Cano, Marta|||0000-0003-0675-9483
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Yücel, Murat|||0000-0002-4705-452X
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Verdejo-García, Antonio
Emotion-regulation strategies are understood to influence food intake. This study examined the neurophysiological underpinnings of negative emotion processing and emotion regulation in individuals with excess weight compared to normal-weight controls. Fifteen participants with excess-weight (body mass index.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Decision Making Impairment, A Shared Vulnerability in Obesity, Gambling Disorder and Substance Use Disorders?

  • Mallorquí-Bagué, Núria|||0000-0003-1434-3162
  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Baños, Rosa|||0000-0003-0626-7665
  • Botella, Cristina|||0000-0001-8783-6959
  • Casanueva, Felipe F.|||0000-0002-9052-8161
  • Crujeiras, Ana B.|||0000-0003-4392-0301
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
  • Frühbeck, Gema|||0000-0002-8305-7154
  • Granero, Roser|||0000-0001-6308-3198
  • Rodríguez, Amaia|||0000-0002-2180-461X
  • Tolosa-Sola, Iris
  • Ortega, Francisco|||0000-0003-0039-1593
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Alvarez Moya, Eva Maria|||0000-0002-3723-3225
  • Ochoa, Cristian|||0000-0002-4508-0951
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Addictions are associated with decision making impairments. The present study explores decision making in Substance use disorder (SUD), Gambling disorder (GD) and Obesity (OB) when assessed by Iowa Gambling Task (IGT) and compares them with healthy controls (HC). For the aims of this study, 591 participants (194 HC, 178 GD, 113 OB, 106 SUD) were assessed according to DSM criteria, completed a sociodemographic interview and conducted the IGT. SUD, GD and OB present impaired decision making when compared to the HC in the overall task and task learning, however no differences are found for the overall performance in the IGT among the clinical groups. Results also reveal some specific learning across the task patterns within the clinical groups: OB maintains negative scores until the third set where learning starts but with a less extend to HC, SUD presents an early learning followed by a progressive although slow improvement and GD presents more random choices with no learning. Decision making impairments are present in the studied clinical samples and they display individual differences in the task learning. Results can help understanding the underlying mechanisms of OB and addiction behaviors as well as improve current clinical treatments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Modulation of Higher-Order Olfaction Components on Executive Functions in Humans

  • Fagundo, Ana Beatriz|||0000-0003-1703-9457
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Giner Bartolomé, Cristina|||0000-0003-3129-5326
  • Islam, Mohammed Anisul|||0000-0001-7240-2971
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Pastor, Antoni|||0000-0003-3692-0696
  • Casanueva, Felipe F.|||0000-0002-9052-8161
  • Crujeiras, Ana B.|||0000-0003-4392-0301
  • Granero, Roser|||0000-0001-6308-3198
  • Baños, Rosa|||0000-0003-0626-7665
  • Botella, Cristina|||0000-0001-8783-6959
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
  • Frühbeck, Gema|||0000-0002-8305-7154
  • Gómez-Ambrosi, Javier|||0000-0001-5601-1604
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
The prefrontal (PFC) and orbitofrontal cortex (OFC) appear to be associated with both executive functions and olfaction. However, there is little data relating olfactory processing and executive functions in humans. The present study aimed at exploring the role of olfaction on executive functioning, making a distinction between primary and more cognitive aspects of olfaction. Three executive tasks of similar difficulty were used. One was used to assess hot executive functions (Iowa Gambling Task-IGT), and two as a measure of cold executive functioning (Stroop Colour and Word Test-SCWT and Wisconsin Card Sorting Test-WCST). Sixty two healthy participants were included: 31 with normosmia and 31 with hyposmia. Olfactory abilities were assessed using the ''Sniffin' Sticks'' test and the olfactory threshold, odour discrimination and odour identification measures were obtained. All participants were female, aged between 18 and 60. Results showed that participants with hyposmia displayed worse performance in decision making (IGT; Cohen's- d = 0.91) and cognitive flexibility (WCST; Cohen's- d between 0.54 and 0.68) compared to those with normosmia. Multiple regression adjusted by the covariates participants' age and education level showed a positive association between odour identification and the cognitive inhibition response (SCWT-interference; Beta = 0.29; p =.034). The odour discrimination capacity was not a predictor of the cognitive executive performance. Our results suggest that both hot and cold executive functions seem to be associated with higher-order olfactory functioning in humans. These results robustly support the hypothesis that olfaction and executive measures have a common neural substrate in PFC and OFC, and suggest that olfaction might be a reliable cognitive marker in psychiatric and neurologic disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dimensions of Compulsive Exercise across Eating Disorder Diagnostic Subtypes and the Validation of the Spanish Version of the Compulsive Exercise Test

  • Sauchelli, Sarah|||0000-0003-3620-7671
  • Arcelus, Jon|||0000-0002-3805-0180
  • Granero, Roser|||0000-0001-6308-3198
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Agüera, Zaida|||0000-0003-4453-4939
  • Pino Gutiérrez, Amparo del|||0000-0002-2854-9850
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Objectives: Compulsive exercise in eating disorders has been traditionally considered as a behavior that serves the purpose of weight/shape control. More recently, it has been postulated that there may be other factors that drive the compulsive need to exercise. This has led to the development of the Compulsive Exercise Test (CET); a self-reported questionnaire that aims to explore the cognitive-behavioral underpinnings of compulsive exercise from a multi-faceted perspective. The objectives of this study were threefold: 1) To validate the Spanish version of the CET; 2) To compare eating disorder diagnostic subtypes and a healthy control group in terms of the factors that drive compulsive exercise as defined by the CET; 3) To explore how the dimensions evaluated in the CET are associated with eating disorder symptoms and general psychopathology. Methods: The CET was administered to a total of 157 patients with an eating disorder (40 anorexia nervosa, 56 bulimia nervosa, 61 eating disorder not-otherwise-specified (EDNOS)) and 128 healthy weight/eating controls. Patients were assessed via a semi-structured interview to reach a DSM-IV-TR diagnosis. Additionally, all participants completed the Symptom Checklist-90-Revised (SCL-90R) and the Eating Disorders Inventory-2 (EDI-2). Results: Confirmatory factor analysis demonstrated adequate goodness-of-fit to the original five-factor model of the CET. Bulimia nervosa and EDNOS patients scored higher in the avoidance and rule-driven behavior, weight control and total CET scales in comparison to the healthy controls, and higher across all scales apart from the exercise rigidity scale compared to the anorexia nervosa patients. Mean scores of the anorexia nervosa patients did not differ to those of the control participants, except for the mood improvement scale where the anorexia nervosa patients obtained a lower mean score. Mean scores between the bulimia nervosa and EDNOS patients were equivalent. The CET scales avoidance and rule-driven behavior, weight of control and total CET scores were positively correlated with the clinical assessment measures of the SCL-90R and EDI-2. Conclusion: Compulsive exercise is a multidimensional construct and the factors driving compulsive exercise differ according to the eating disorder diagnostic subtype. This should be taken into account when addressing compulsive exercise during the treatment of eating disorders.